Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2015 | 12-2014 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 3,040 | 5,730 |
| Marketable Securities | 2,118 | 2,010 |
| Receivables | 1,666 | 280 |
| Other current assets | 64 | 80 |
| TOTAL | $6,888 | $8,100 |
| Non-Current Assets | ||
| PPE Net | 4,691 | N/A |
| Other Non-Current Assets | 668 | 0 |
| TOTAL | $5,359 | $N/A |
| Total Assets | $12,247 | $12,500 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 2,280 | 180 |
| Other current liabilities | N/A | 1,630 |
| TOTAL | $2,280 | $1,850 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 952 | 1,130 |
| TOTAL | $952 | $1,130 |
| Total Liabilities | $3,232 | $3,020 |
| Shareholders' Equity | ||
| Common Shares | 717 | 670 |
| Retained earnings | -46,922 | -43,000 |
| Other shareholders' equity | 0 | 1,920 |
| TOTAL | $9,015 | $9,480 |
| Total Liabilities And Equity | $12,247 | $12,500 |